Balañá
C, Etxaniz
O, Bugés
C, Martínez
A.
Approval denied by the European Medicines Agency (EMA) for bevacizumab in
the treatment of high-grade glioma recurrence: a good idea or a grave error?
Clin Transl Oncol. 2011 Mar;13(3):209-10.
Abstract |
Related articles
Weller
M, Wick W.
Are we ready to demystify age in glioblastoma? Or does older age matter in
glioblastoma?
Neuro Oncol. 2011 Apr;13(4):365-6.
Abstract |
Related articles
.JPG){kind=small}
.gif){kind=small}
